Amlodipine And Valsartan
Product Images NDC 45865-882

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 45865-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (882)

Amlodipine and Valsartan Tablets 10 mg / 320 mg label by Medsource Pharmaceuticals. The label includes instructions to take tablets as directed by a physician and warnings not to use if pregnant. It specifies the tablets as generic for Exforge and provides package lot information and expiration date fields. The label features peelable sections for additional information.*

FDA Label Image

Image-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 01)

A line graph showing the percentage of subjects with systolic blood pressure (SBP) below 140 mmHg plotted against baseline SBP values from 140 to 180 mmHg. It compares responses between Amlodipine and Valsartan tablets (10/320 mg), Valsartan 320 mg, Amlodipine 10 mg, and placebo groups, illustrating treatment effectiveness over baseline SBP.*

FDA Label Image

Image-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 02)

A line graph comparing the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg over a blood pressure range from 95 to 110 mmHg. The graph shows data for Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, with Amlodipine and Valsartan combination consistently achieving the highest percentage.*

FDA Label Image

Image-03 (B5a13389 E39e 4825 A6dc 4ba50d432aed 03)

A line graph showing the percentage of systolic blood pressure (SBP) below 130 mmHg over a range of baseline SBP values (140 to 180 mmHg). The plot compares Amlodipine and Valsartan tablets (10/320 mg) with Valsartan 320 mg, Amlodipine 10 mg, and placebo groups, each represented by different symbols.*

FDA Label Image

Image-04 (B5a13389 E39e 4825 A6dc 4ba50d432aed 04)

A line graph showing the percentage of baseline diastolic blood pressure less than 80 mmHg (% DBP <80 mmHg) versus baseline DBP (mmHg) for different treatments: Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The graph includes a legend identifying each treatment's corresponding data points.*

FDA Label Image

Amlodipineandvals-figure-01 (B5a13389 E39e 4825 A6dc 4ba50d432aed 05)

Chemical structure of the active ingredients in Amlodipine and Valsartan, showing molecular diagrams with labeled chemical groups including benzene rings, chlorine (Cl), ester groups, and sulfonic acid (SO3H) groups.*

FDA Label Image

Amlodipineandvals-figure-02 (B5a13389 E39e 4825 A6dc 4ba50d432aed 06)

Chemical structure of the active ingredient in Amlodipine and Valsartan, showing molecular bonds and functional groups in a detailed 2D diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.